Clinical trial
Darbepoetin Alfa With or Without Intravenous (IV) Iron
NCT00401544 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00401544 |
|---|---|
| Title | Darbepoetin Alfa With or Without Intravenous (IV) Iron |
| Official title | Once Per Cycle Treatment of Anemia With Darbepoetin Alfa With Iron in Subjects With Non Myeloid Malignancies |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Non-Myeloid Malignancies |
| Intervention type | Drug |
| Interventions | darbepoetin alfa, IV iron dextran |
| Enrollment | 243 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Mar 1, 2008 |
| First posted | Nov 20, 2006 |
| Last update posted | Jan 29, 2014 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: